| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.556 | 0.011 | 0.556 | Hypoglycemic | 0.341 0.04 DBMET01628 0.3 0.053 DBMET01629 0.341 0.04 DBMET00199 0.3 0.053 DBMET00200 0.443 0.021 DBMET00201 | ||
| 0.546 | 0.005 | 0.554 | Diuretic | 0.218 0.038 DBMET01628 0.204 0.043 DBMET01629 0.218 0.038 DBMET00199 0.204 0.043 DBMET00200 0.441 0.011 DBMET00201 0.554 0.005 DBMET00977 | DBMET00977 | |
| 0.45 | 0.021 | 0.52 | Cardiotonic | 0.173 0.148 DBMET01628 0.173 0.148 DBMET00199 0.52 0.013 DBMET00201 | DBMET00201 | |
| 0.411 | 0.003 | 0.598 | Electrolyte absorption antagonist | 0.322 0.004 DBMET01628 0.278 0.004 DBMET01629 0.322 0.004 DBMET00199 0.278 0.004 DBMET00200 0.399 0.003 DBMET00201 0.598 0.002 DBMET00977 | DBMET00977 | |
| 0.394 | 0.004 | 0.441 | Carbonic anhydrase XII inhibitor | 0.096 0.021 DBMET01628 0.153 0.012 DBMET01629 0.096 0.021 DBMET00199 0.153 0.012 DBMET00200 0.242 0.006 DBMET00201 0.441 0.004 DBMET00977 | DBMET00977 | |
| 0.404 | 0.026 | 0.404 | Platelet antagonist | 0.324 0.045 DBMET00201 | ||
| 0.364 | 0.008 | 0.364 | Insulin secretagoues | 0.159 0.066 DBMET01628 0.154 0.071 DBMET01629 0.159 0.066 DBMET00199 0.154 0.071 DBMET00200 0.331 0.009 DBMET00201 | ||
| 0.368 | 0.021 | 0.368 | Anesthetic general | 0.268 0.043 DBMET00201 0.2 0.074 DBMET00977 | ||
| 0.404 | 0.059 | 0.404 | Calpain 2 inhibitor | 0.216 0.175 DBMET01628 0.211 0.178 DBMET01629 0.216 0.175 DBMET00199 0.211 0.178 DBMET00200 0.284 0.125 DBMET00201 0.347 0.088 DBMET00977 | ||
| 0.346 | 0.004 | 0.439 | Carbonic anhydrase IX inhibitor | 0.077 0.028 DBMET01628 0.113 0.017 DBMET01629 0.077 0.028 DBMET00199 0.113 0.017 DBMET00200 0.238 0.006 DBMET00201 0.439 0.004 DBMET00977 | DBMET00977 | |
| 0.342 | 0.004 | 0.428 | Carbonic anhydrase inhibitor | 0.102 0.026 DBMET01628 0.182 0.011 DBMET01629 0.102 0.026 DBMET00199 0.182 0.011 DBMET00200 0.235 0.007 DBMET00201 0.428 0.004 DBMET00977 | DBMET00977 | |
| 0.323 | 0.004 | 0.383 | Carbonic anhydrase I inhibitor | 0.076 0.027 DBMET01628 0.114 0.015 DBMET01629 0.076 0.027 DBMET00199 0.114 0.015 DBMET00200 0.217 0.005 DBMET00201 0.383 0.003 DBMET00977 | DBMET00977 | |
| 0.311 | 0.003 | 0.311 | Thromboxane antagonist | 0.132 0.005 DBMET01628 0.114 0.008 DBMET01629 0.132 0.005 DBMET00199 0.114 0.008 DBMET00200 0.147 0.005 DBMET00201 0.086 0.017 DBMET00977 | ||
| 0.286 | 0.003 | 0.286 | Thromboxane A2 antagonist | 0.116 0.005 DBMET01628 0.103 0.007 DBMET01629 0.116 0.005 DBMET00199 0.103 0.007 DBMET00200 0.133 0.004 DBMET00201 0.079 0.016 DBMET00977 | ||
| 0.345 | 0.066 | 0.345 | Antithrombotic | 0.211 0.164 DBMET01628 0.199 0.178 DBMET01629 0.211 0.164 DBMET00199 0.199 0.178 DBMET00200 0.288 0.097 DBMET00201 0.222 0.152 DBMET00977 | ||
| 0.283 | 0.004 | 0.283 | Carbonic anhydrase stimulant | 0.067 0.034 DBMET01628 0.083 0.024 DBMET01629 0.067 0.034 DBMET00199 0.083 0.024 DBMET00200 0.159 0.01 DBMET00201 0.137 0.012 DBMET00977 | ||
| 0.287 | 0.013 | 0.287 | Aldehyde dehydrogenase inhibitor | 0.134 0.059 DBMET01628 0.118 0.073 DBMET01629 0.134 0.059 DBMET00199 0.118 0.073 DBMET00200 0.146 0.05 DBMET00201 0.106 0.088 DBMET00977 | ||
| 0.277 | 0.004 | 0.386 | Carbonic anhydrase II inhibitor | 0.074 0.028 DBMET01628 0.136 0.012 DBMET01629 0.074 0.028 DBMET00199 0.136 0.012 DBMET00200 0.202 0.006 DBMET00201 0.386 0.003 DBMET00977 | DBMET00977 | |
| 0.301 | 0.034 | 0.301 | Platelet adhesion inhibitor | 0.157 0.098 DBMET00201 | ||
| 0.3 | 0.045 | 0.438 | 5 Hydroxytryptamine uptake stimulant | 0.333 0.031 DBMET01628 0.344 0.027 DBMET01629 0.333 0.031 DBMET00199 0.344 0.027 DBMET00200 0.35 0.026 DBMET00201 0.438 0.009 DBMET00977 | DBMET00977 | |
| 0.26 | 0.005 | 0.26 | Prostaglandin E2 antagonist | 0.082 0.019 DBMET01628 0.05 0.035 DBMET01629 0.082 0.019 DBMET00199 0.05 0.035 DBMET00200 0.17 0.007 DBMET00201 0.048 0.038 DBMET00977 | ||
| 0.247 | 0.005 | 0.247 | Cannabinoid receptor antagonist | 0.101 0.028 DBMET00201 0.097 0.03 DBMET00977 | ||
| 0.308 | 0.067 | 0.308 | 5 Hydroxytryptamine release stimulant | 0.176 0.145 DBMET01628 0.176 0.145 DBMET00199 0.166 0.158 DBMET00201 0.308 0.067 DBMET00977 | ||
| 0.229 | 0.001 | 0.229 | Carbonic anhydrase I stimulant | 0.091 0.005 DBMET01628 0.098 0.005 DBMET01629 0.091 0.005 DBMET00199 0.098 0.005 DBMET00200 0.157 0.003 DBMET00201 0.047 0.018 DBMET00977 | ||
| 0.239 | 0.015 | 0.239 | Nav1.3 sodium channel blocker | 0.141 0.054 DBMET01628 0.147 0.05 DBMET01629 0.141 0.054 DBMET00199 0.147 0.05 DBMET00200 0.165 0.039 DBMET00201 0.138 0.057 DBMET00977 | ||
| 0.227 | 0.005 | 0.227 | Cannabinoid CB1 receptor antagonist | 0.1 0.016 DBMET00201 0.101 0.016 DBMET00977 | ||
| 0.222 | 0.002 | 0.222 | Carbonic anhydrase II stimulant | 0.087 0.007 DBMET01628 0.093 0.006 DBMET01629 0.087 0.007 DBMET00199 0.093 0.006 DBMET00200 0.147 0.003 DBMET00201 0.111 0.004 DBMET00977 | ||
| 0.286 | 0.067 | 0.286 | Insulysin inhibitor | 0.196 0.164 DBMET01629 0.196 0.164 DBMET00200 0.244 0.102 DBMET00201 | ||
| 0.23 | 0.014 | 0.23 | Chemokine receptor antagonist | 0.106 0.057 DBMET01628 0.106 0.057 DBMET00199 0.179 0.023 DBMET00201 0.161 0.028 DBMET00977 | ||
| 0.261 | 0.046 | 0.261 | Neuropeptide Y2 antagonist | 0.174 0.172 DBMET01629 0.174 0.172 DBMET00200 0.238 0.068 DBMET00201 0.197 0.126 DBMET00977 | ||
| 0.265 | 0.052 | 0.265 | Calpain inhibitor | 0.173 0.144 DBMET01628 0.184 0.13 DBMET01629 0.173 0.144 DBMET00199 0.184 0.13 DBMET00200 0.233 0.081 DBMET00201 0.221 0.093 DBMET00977 | ||
| 0.209 | 0.006 | 0.346 | Carbonic anhydrase V inhibitor | 0.085 0.033 DBMET01628 0.162 0.012 DBMET01629 0.085 0.033 DBMET00199 0.162 0.012 DBMET00200 0.224 0.005 DBMET00201 0.346 0.003 DBMET00977 | DBMET00977 | |
| 0.201 | 0.002 | 0.201 | Bombesin 3 receptor antagonist | 0.131 0.005 DBMET01628 0.134 0.005 DBMET01629 0.131 0.005 DBMET00199 0.134 0.005 DBMET00200 0.172 0.003 DBMET00201 | ||
| 0.203 | 0.01 | 0.203 | Metalloproteinase-2 inhibitor | 0.08 0.052 DBMET01628 0.093 0.042 DBMET01629 0.08 0.052 DBMET00199 0.093 0.042 DBMET00200 0.147 0.02 DBMET00201 0.135 0.023 DBMET00977 | ||
| 0.267 | 0.076 | 0.829 | Aldehyde oxidase inhibitor | 0.475 0.036 DBMET01628 0.364 0.053 DBMET01629 0.475 0.036 DBMET00199 0.364 0.053 DBMET00200 0.407 0.046 DBMET00201 0.829 0.004 DBMET00977 | DBMET00977 | |
| 0.193 | 0.005 | 0.4 | Carbonic anhydrase VII inhibitor | 0.048 0.029 DBMET01628 0.072 0.014 DBMET01629 0.048 0.029 DBMET00199 0.072 0.014 DBMET00200 0.155 0.006 DBMET00201 0.4 0.003 DBMET00977 | DBMET00977 | |
| 0.188 | 0.005 | 0.3 | Carbonic anhydrase VA inhibitor | 0.089 0.031 DBMET01628 0.102 0.024 DBMET01629 0.089 0.031 DBMET00199 0.102 0.024 DBMET00200 0.196 0.005 DBMET00201 0.3 0.003 DBMET00977 | DBMET00977 | |
| 0.18 | 0.004 | 0.18 | Potassium channel (ATP-sensitive) blocker | 0.152 0.005 DBMET01628 0.075 0.034 DBMET01629 0.152 0.005 DBMET00199 0.075 0.034 DBMET00200 0.158 0.005 DBMET00201 0.074 0.035 DBMET00977 | ||
| 0.19 | 0.02 | 0.599 | Carbonic anhydrase XV inhibitor | 0.128 0.041 DBMET01628 0.154 0.029 DBMET01629 0.128 0.041 DBMET00199 0.154 0.029 DBMET00200 0.301 0.008 DBMET00201 0.599 0.003 DBMET00977 | DBMET00977 | |
| 0.173 | 0.003 | 0.173 | Potassium channel Kv1.1 blocker | 0.039 0.024 DBMET01628 0.041 0.021 DBMET01629 0.039 0.024 DBMET00199 0.041 0.021 DBMET00200 0.084 0.005 DBMET00201 0.046 0.016 DBMET00977 | ||
| 0.246 | 0.079 | 0.275 | 5 Hydroxytryptamine 1E antagonist | 0.178 0.156 DBMET01629 0.178 0.156 DBMET00200 0.256 0.069 DBMET00201 0.275 0.049 DBMET00977 | DBMET00977 | |
| 0.174 | 0.011 | 0.174 | Metalloproteinase-9 inhibitor | 0.078 0.045 DBMET01628 0.089 0.038 DBMET01629 0.078 0.045 DBMET00199 0.089 0.038 DBMET00200 0.141 0.018 DBMET00201 0.129 0.022 DBMET00977 | ||
| 0.219 | 0.057 | 0.575 | Non-steroidal antiinflammatory agent | 0.214 0.061 DBMET01629 0.214 0.061 DBMET00200 0.248 0.043 DBMET00201 0.575 0.005 DBMET00977 | DBMET00977 | |
| 0.164 | 0.005 | 0.199 | Bcl2 antagonist | 0.147 0.005 DBMET01628 0.141 0.006 DBMET01629 0.147 0.005 DBMET00199 0.141 0.006 DBMET00200 0.199 0.004 DBMET00201 0.144 0.006 DBMET00977 | DBMET00201 | |
| 0.175 | 0.017 | 0.175 | Neuropeptide Y antagonist | 0.125 0.028 DBMET00201 | ||
| 0.223 | 0.066 | 0.223 | Platelet aggregation inhibitor | |||
| 0.168 | 0.015 | 0.168 | CC chemokine receptor antagonist | 0.076 0.055 DBMET01628 0.076 0.055 DBMET00199 0.137 0.021 DBMET00201 0.127 0.024 DBMET00977 | ||
| 0.164 | 0.011 | 0.164 | Neutrophil collagenase inhibitor | 0.077 0.034 DBMET01628 0.072 0.038 DBMET01629 0.077 0.034 DBMET00199 0.072 0.038 DBMET00200 0.134 0.014 DBMET00201 0.089 0.027 DBMET00977 | ||
| 0.174 | 0.023 | 0.255 | Pregnane X receptor agonist | 0.146 0.06 DBMET01628 0.163 0.034 DBMET01629 0.146 0.06 DBMET00199 0.163 0.034 DBMET00200 0.168 0.028 DBMET00201 0.255 0.005 DBMET00977 | DBMET00977 | |
| 0.153 | 0.003 | 0.153 | Vanilloid 4 agonist | 0.115 0.008 DBMET01628 0.104 0.014 DBMET01629 0.115 0.008 DBMET00199 0.104 0.014 DBMET00200 0.127 0.005 DBMET00201 0.131 0.005 DBMET00977 | ||
| 0.153 | 0.003 | 0.168 | Fructose-1,6-bisphosphatase inhibitor | 0.059 0.018 DBMET01628 0.075 0.01 DBMET01629 0.059 0.018 DBMET00199 0.075 0.01 DBMET00200 0.168 0.003 DBMET00201 0.069 0.013 DBMET00977 | DBMET00201 | |
| 0.259 | 0.113 | 0.259 | Thyroid hormone beta antagonist | 0.225 0.135 DBMET01628 0.225 0.135 DBMET00199 0.218 0.14 DBMET00977 | ||
| 0.181 | 0.041 | 0.471 | Alkaline phosphatase inhibitor | 0.243 0.021 DBMET01628 0.185 0.04 DBMET01629 0.243 0.021 DBMET00199 0.185 0.04 DBMET00200 0.267 0.017 DBMET00201 0.471 0.004 DBMET00977 | DBMET00977 | |
| 0.155 | 0.02 | 0.499 | Carbonic anhydrase VI inhibitor | 0.098 0.041 DBMET01628 0.124 0.028 DBMET01629 0.098 0.041 DBMET00199 0.124 0.028 DBMET00200 0.268 0.008 DBMET00201 0.499 0.003 DBMET00977 | DBMET00977 | |
| 0.146 | 0.011 | 0.146 | Prostaglandin antagonist | 0.053 0.037 DBMET01628 0.053 0.037 DBMET00199 0.095 0.018 DBMET00201 | ||
| 0.216 | 0.081 | 0.319 | Peptidyltransferase inhibitor | 0.169 0.149 DBMET01628 0.183 0.123 DBMET01629 0.169 0.149 DBMET00199 0.183 0.123 DBMET00200 0.164 0.159 DBMET00201 0.319 0.019 DBMET00977 | DBMET00977 | |
| 0.133 | 0.002 | 0.133 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.031 0.007 DBMET01628 0.039 0.004 DBMET01629 0.031 0.007 DBMET00199 0.039 0.004 DBMET00200 0.108 0.002 DBMET00201 0.034 0.005 DBMET00977 | ||
| 0.168 | 0.038 | 0.168 | Adenylate cyclase stimulant | 0.147 0.067 DBMET01628 0.146 0.07 DBMET01629 0.147 0.067 DBMET00199 0.146 0.07 DBMET00200 0.15 0.062 DBMET00201 0.133 0.095 DBMET00977 | ||
| 0.132 | 0.003 | 0.132 | Potassium channel (Inward rectifier) activator | 0.053 0.031 DBMET01628 0.054 0.029 DBMET01629 0.053 0.031 DBMET00199 0.054 0.029 DBMET00200 0.112 0.004 DBMET00201 0.1 0.005 DBMET00977 | ||
| 0.133 | 0.006 | 0.133 | Beta 1 adrenoreceptor antagonist | 0.072 0.024 DBMET01628 0.067 0.029 DBMET01629 0.072 0.024 DBMET00199 0.067 0.029 DBMET00200 0.076 0.021 DBMET00977 | ||
| 0.132 | 0.005 | 0.331 | Carbonic anhydrase XIV inhibitor | 0.058 0.026 DBMET01628 0.078 0.017 DBMET01629 0.058 0.026 DBMET00199 0.078 0.017 DBMET00200 0.114 0.008 DBMET00201 0.331 0.003 DBMET00977 | DBMET00977 | |
| 0.128 | 0.003 | 0.128 | Potassium channel (ATP-sensitive) activator | 0.049 0.031 DBMET01628 0.05 0.03 DBMET01629 0.049 0.031 DBMET00199 0.05 0.03 DBMET00200 0.107 0.004 DBMET00201 0.096 0.005 DBMET00977 | ||
| 0.248 | 0.125 | 0.248 | Thyroid hormone antagonist | 0.226 0.14 DBMET01628 0.226 0.14 DBMET00199 0.214 0.15 DBMET00977 | ||
| 0.132 | 0.009 | 0.132 | Sphingosine 1-phosphate receptor antagonist | 0.087 0.034 DBMET01628 0.091 0.029 DBMET01629 0.087 0.034 DBMET00199 0.091 0.029 DBMET00200 0.084 0.038 DBMET00201 0.109 0.017 DBMET00977 | ||
| 0.123 | 0.001 | 0.123 | Carbonic anhydrase IV stimulant | 0.028 0.004 DBMET01628 0.032 0.004 DBMET01629 0.028 0.004 DBMET00199 0.032 0.004 DBMET00200 0.071 0.002 DBMET00201 0.014 0.013 DBMET00977 | ||
| 0.161 | 0.039 | 0.163 | Cathepsin H inhibitor | 0.163 0.038 DBMET00201 0.136 0.057 DBMET00977 | DBMET00201 | |
| 0.124 | 0.005 | 0.124 | Thromboxane synthase inhibitor | 0.057 0.032 DBMET01628 0.065 0.021 DBMET01629 0.057 0.032 DBMET00199 0.065 0.021 DBMET00200 0.087 0.009 DBMET00201 | ||
| 0.122 | 0.005 | 0.122 | Sphingosine 1-phosphate receptor 1 antagonist | 0.057 0.035 DBMET01628 0.074 0.016 DBMET01629 0.057 0.035 DBMET00199 0.074 0.016 DBMET00200 0.064 0.023 DBMET00201 0.109 0.007 DBMET00977 | ||
| 0.152 | 0.037 | 0.189 | Aminopeptidase B inhibitor | 0.109 0.059 DBMET01628 0.124 0.05 DBMET01629 0.109 0.059 DBMET00199 0.124 0.05 DBMET00200 0.189 0.024 DBMET00201 0.107 0.06 DBMET00977 | DBMET00201 | |
| 0.131 | 0.021 | 0.131 | Adrenaline agonist | 0.1 0.037 DBMET01628 0.099 0.037 DBMET01629 0.1 0.037 DBMET00199 0.099 0.037 DBMET00200 | ||
| 0.117 | 0.01 | 0.117 | Beta 3 adrenoreceptor antagonist | 0.063 0.048 DBMET01628 0.076 0.027 DBMET01629 0.063 0.048 DBMET00199 0.076 0.027 DBMET00200 0.07 0.035 DBMET00977 | ||
| 0.258 | 0.153 | 0.282 | Beta lactamase inhibitor | 0.282 0.142 DBMET00201 0.203 0.183 DBMET00977 | DBMET00201 | |
| 0.123 | 0.019 | 0.123 | Matrix metalloproteinase inhibitor | 0.061 0.053 DBMET01628 0.065 0.048 DBMET01629 0.061 0.053 DBMET00199 0.065 0.048 DBMET00200 0.097 0.028 DBMET00201 0.072 0.042 DBMET00977 | ||
| 0.12 | 0.018 | 0.154 | Thrombin inhibitor | 0.094 0.029 DBMET01628 0.09 0.032 DBMET01629 0.094 0.029 DBMET00199 0.09 0.032 DBMET00200 0.154 0.01 DBMET00201 0.09 0.033 DBMET00977 | DBMET00201 | |
| 0.109 | 0.007 | 0.109 | Beta 2 adrenoreceptor antagonist | 0.046 0.043 DBMET01628 0.055 0.03 DBMET01629 0.046 0.043 DBMET00199 0.055 0.03 DBMET00200 0.056 0.028 DBMET00977 | ||
| 0.115 | 0.014 | 0.229 | Potassium channel Kv1.5 blocker | 0.082 0.024 DBMET00201 0.229 0.005 DBMET00977 | DBMET00977 | |
| 0.157 | 0.055 | 0.157 | Neuropeptide Y1 antagonist | 0.13 0.1 DBMET00201 | ||
| 0.104 | 0.005 | 0.105 | Prostaglandin EP3 antagonist | 0.04 0.014 DBMET01628 0.036 0.016 DBMET01629 0.04 0.014 DBMET00199 0.036 0.016 DBMET00200 0.105 0.005 DBMET00201 | DBMET00201 | |
| 0.219 | 0.12 | 0.224 | Gastrin inhibitor | 0.196 0.155 DBMET00201 0.224 0.114 DBMET00977 | DBMET00977 | |
| 0.139 | 0.041 | 0.225 | Interleukin 8 antagonist | 0.158 0.029 DBMET00201 0.225 0.008 DBMET00977 | DBMET00977 | |
| 0.116 | 0.018 | 0.116 | Epoxide hydrolase inhibitor | 0.084 0.038 DBMET00977 | ||
| 0.104 | 0.006 | 0.241 | Carbonic anhydrase IV inhibitor | 0.045 0.028 DBMET01628 0.059 0.02 DBMET01629 0.045 0.028 DBMET00199 0.059 0.02 DBMET00200 0.12 0.005 DBMET00201 0.241 0.003 DBMET00977 | DBMET00977 | |
| 0.173 | 0.076 | 0.252 | Succinate dehydrogenase inhibitor | 0.178 0.07 DBMET01628 0.184 0.063 DBMET01629 0.178 0.07 DBMET00199 0.184 0.063 DBMET00200 0.202 0.048 DBMET00201 0.252 0.021 DBMET00977 | DBMET00977 | |
| 0.153 | 0.057 | 0.314 | Sodium channel blocker | 0.314 0.009 DBMET00201 0.311 0.009 DBMET00977 | DBMET00201 | |
| 0.249 | 0.155 | 0.429 | GABA C receptor rho-3 antagonist | 0.256 0.149 DBMET00201 0.429 0.049 DBMET00977 | DBMET00977 | |
| 0.098 | 0.006 | 0.108 | Collagenase inhibitor | 0.058 0.018 DBMET01628 0.059 0.017 DBMET01629 0.058 0.018 DBMET00199 0.059 0.017 DBMET00200 0.108 0.005 DBMET00201 | DBMET00201 | |
| 0.098 | 0.006 | 0.115 | Bcl-xL inhibitor | 0.091 0.008 DBMET01628 0.083 0.01 DBMET01629 0.091 0.008 DBMET00199 0.083 0.01 DBMET00200 0.115 0.005 DBMET00201 0.072 0.017 DBMET00977 | DBMET00201 | |
| 0.104 | 0.015 | 0.104 | Beta adrenoreceptor antagonist | 0.069 0.04 DBMET01628 0.068 0.041 DBMET01629 0.069 0.04 DBMET00199 0.068 0.041 DBMET00200 0.072 0.035 DBMET00977 | ||
| 0.114 | 0.026 | 0.126 | Glutathione S-transferase inhibitor | 0.125 0.02 DBMET01628 0.077 0.067 DBMET01629 0.125 0.02 DBMET00199 0.077 0.067 DBMET00200 0.126 0.02 DBMET00201 0.085 0.054 DBMET00977 | DBMET00201 | |
| 0.097 | 0.012 | 0.097 | Glycine transporter inhibitor | 0.082 0.016 DBMET00201 0.045 0.036 DBMET00977 | ||
| 0.098 | 0.014 | 0.098 | Matrix metalloproteinase 1 inhibitor | 0.049 0.039 DBMET01628 0.05 0.038 DBMET01629 0.049 0.039 DBMET00199 0.05 0.038 DBMET00200 0.075 0.024 DBMET00201 0.058 0.033 DBMET00977 | ||
| 0.115 | 0.031 | 0.442 | Carbonic anhydrase XIII inhibitor | 0.089 0.044 DBMET01628 0.117 0.03 DBMET01629 0.089 0.044 DBMET00199 0.117 0.03 DBMET00200 0.244 0.009 DBMET00201 0.442 0.004 DBMET00977 | DBMET00977 | |
| 0.124 | 0.042 | 0.567 | Carbonic anhydrase III inhibitor | 0.12 0.045 DBMET01628 0.134 0.036 DBMET01629 0.12 0.045 DBMET00199 0.134 0.036 DBMET00200 0.216 0.014 DBMET00201 0.567 0.003 DBMET00977 | DBMET00977 | |
| 0.163 | 0.082 | 0.206 | Phospholipase C inhibitor | 0.15 0.107 DBMET01628 0.144 0.118 DBMET01629 0.15 0.107 DBMET00199 0.144 0.118 DBMET00200 0.206 0.04 DBMET00201 0.144 0.118 DBMET00977 | DBMET00201 | |
| 0.085 | 0.004 | 0.085 | Angiotensin AT2 receptor antagonist | 0.047 0.01 DBMET01628 0.05 0.01 DBMET01629 0.047 0.01 DBMET00199 0.05 0.01 DBMET00200 0.062 0.008 DBMET00201 | ||
| 0.27 | 0.191 | 0.27 | Cyclophilin D inhibitor | |||
| 0.153 | 0.076 | 0.231 | Hexokinase inhibitor | 0.181 0.049 DBMET01628 0.183 0.047 DBMET01629 0.181 0.049 DBMET00199 0.183 0.047 DBMET00200 0.231 0.022 DBMET00201 0.212 0.029 DBMET00977 | DBMET00201 | |
| 0.08 | 0.004 | 0.08 | Integrin alpha2 antagonist | 0.068 0.005 DBMET00201 0.059 0.008 DBMET00977 | ||
| 0.099 | 0.025 | 0.099 | CXC chemokine receptor antagonist | 0.066 0.056 DBMET00201 0.065 0.057 DBMET00977 | ||
| 0.078 | 0.005 | 0.078 | Prostaglandin EP4 antagonist | 0.023 0.022 DBMET01628 0.023 0.022 DBMET00199 0.026 0.018 DBMET00201 | ||
| 0.09 | 0.019 | 0.355 | Carbonic anhydrase VB inhibitor | 0.064 0.032 DBMET01629 0.064 0.032 DBMET00200 0.153 0.009 DBMET00201 0.355 0.003 DBMET00977 | DBMET00977 | |
| 0.092 | 0.021 | 0.121 | Trypsin inhibitor | 0.078 0.028 DBMET01628 0.072 0.031 DBMET01629 0.078 0.028 DBMET00199 0.072 0.031 DBMET00200 0.121 0.011 DBMET00201 0.086 0.024 DBMET00977 | DBMET00201 | |
| 0.087 | 0.018 | 0.104 | Prostaglandin F2 alpha antagonist | 0.087 0.018 DBMET01628 0.075 0.027 DBMET01629 0.087 0.018 DBMET00199 0.075 0.027 DBMET00200 0.104 0.01 DBMET00201 | DBMET00201 | |
| 0.096 | 0.028 | 0.096 | Ca(v)3.1 blocker | |||
| 0.079 | 0.013 | 0.079 | Potassium channel (Inward rectifier) blocker | 0.071 0.017 DBMET00201 | ||
| 0.131 | 0.066 | 0.157 | CC chemokine 6 receptor antagonist | 0.146 0.028 DBMET01628 0.143 0.033 DBMET01629 0.146 0.028 DBMET00199 0.143 0.033 DBMET00200 0.151 0.021 DBMET00201 0.157 0.015 DBMET00977 | DBMET00977 | |
| 0.073 | 0.009 | 0.113 | CC chemokine 4 receptor antagonist | 0.086 0.005 DBMET00201 0.113 0.004 DBMET00977 | DBMET00977 | |
| 0.079 | 0.016 | 0.079 | Glucosylceramidase inhibitor | 0.052 0.044 DBMET01628 0.059 0.032 DBMET01629 0.052 0.044 DBMET00199 0.059 0.032 DBMET00200 0.078 0.016 DBMET00977 | ||
| 0.076 | 0.014 | 0.076 | Purinergic P2Y antagonist | 0.04 0.037 DBMET00201 | ||
| 0.131 | 0.071 | 0.157 | Sphingosine 1-phosphate receptor 2 antagonist | 0.157 0.033 DBMET00977 | DBMET00977 | |
| 0.064 | 0.005 | 0.064 | Angiotensin AT1 receptor antagonist | 0.045 0.025 DBMET01628 0.048 0.021 DBMET01629 0.045 0.025 DBMET00199 0.048 0.021 DBMET00200 0.043 0.028 DBMET00201 | ||
| 0.204 | 0.147 | 0.348 | 12-Lipoxygenase inhibitor | 0.348 0.058 DBMET01628 0.287 0.087 DBMET01629 0.348 0.058 DBMET00199 0.287 0.087 DBMET00200 0.262 0.102 DBMET00201 0.295 0.082 DBMET00977 | DBMET00199 | |
| 0.103 | 0.045 | 0.103 | Potassium channel activator | 0.098 0.05 DBMET00201 | ||
| 0.062 | 0.005 | 0.08 | CXC chemokine 2 receptor antagonist | 0.029 0.015 DBMET01628 0.028 0.016 DBMET01629 0.029 0.015 DBMET00199 0.028 0.016 DBMET00200 0.05 0.005 DBMET00201 0.08 0.004 DBMET00977 | DBMET00977 | |
| 0.175 | 0.119 | 0.26 | 5 Hydroxytryptamine 3E antagonist | 0.213 0.044 DBMET00201 0.26 0.012 DBMET00977 | DBMET00977 | |
| 0.064 | 0.009 | 0.064 | Farnesoid X receptor agonist | 0.042 0.021 DBMET00201 | ||
| 0.059 | 0.005 | 0.059 | Angiotensin II receptor antagonist | 0.034 0.024 DBMET01628 0.036 0.02 DBMET01629 0.034 0.024 DBMET00199 0.036 0.02 DBMET00200 | ||
| 0.21 | 0.156 | 0.21 | Cholesterol antagonist | 0.196 0.168 DBMET00977 | ||
| 0.128 | 0.074 | 0.128 | Nav1.2 sodium channel blocker | 0.106 0.101 DBMET00201 0.113 0.092 DBMET00977 | ||
| 0.116 | 0.062 | 0.264 | Sphingosine 1-phosphate receptor 2 agonist | 0.114 0.066 DBMET00201 0.264 0.005 DBMET00977 | DBMET00977 | |
| 0.163 | 0.11 | 0.252 | Focal adhesion kinase 2 inhibitor | 0.243 0.041 DBMET00201 0.252 0.036 DBMET00977 | DBMET00977 | |
| 0.057 | 0.005 | 0.057 | Bombesin agonist | |||
| 0.07 | 0.019 | 0.07 | Metalloproteinase-3 inhibitor | 0.055 0.028 DBMET00201 0.059 0.024 DBMET00977 | ||
| 0.131 | 0.08 | 0.131 | Nav1.6 sodium channel blocker | 0.126 0.087 DBMET00977 | ||
| 0.059 | 0.009 | 0.076 | Aggrecanase 1 inhibitor | 0.044 0.02 DBMET01628 0.049 0.014 DBMET01629 0.044 0.02 DBMET00199 0.049 0.014 DBMET00200 0.076 0.005 DBMET00201 0.044 0.019 DBMET00977 | DBMET00201 | |
| 0.07 | 0.02 | 0.07 | Beta 2 adrenoreceptor agonist | 0.061 0.044 DBMET01629 0.061 0.044 DBMET00200 0.06 0.052 DBMET00201 0.062 0.042 DBMET00977 | ||
| 0.112 | 0.063 | 0.123 | 5 Hydroxytryptamine 3A agonist | 0.123 0.053 DBMET00201 0.122 0.055 DBMET00977 | DBMET00201 | |
| 0.193 | 0.144 | 0.4 | Transcription factor STAT3 inhibitor | 0.233 0.098 DBMET00201 0.4 0.018 DBMET00977 | DBMET00977 | |
| 0.087 | 0.038 | 0.124 | GABA aminotransferase inhibitor | 0.088 0.037 DBMET01628 0.089 0.037 DBMET01629 0.088 0.037 DBMET00199 0.089 0.037 DBMET00200 0.124 0.014 DBMET00201 0.077 0.051 DBMET00977 | DBMET00201 | |
| 0.076 | 0.027 | 0.083 | Collagenase 3 inhibitor | 0.08 0.025 DBMET00201 0.083 0.023 DBMET00977 | DBMET00977 | |
| 0.086 | 0.038 | 0.086 | Viral attachment inhibitor | |||
| 0.069 | 0.024 | 0.069 | Cannabinoid CB2 receptor antagonist | |||
| 0.05 | 0.005 | 0.05 | Bombesin 3 receptor agonist | |||
| 0.063 | 0.018 | 0.063 | CC chemokine 3 receptor antagonist | |||
| 0.122 | 0.077 | 0.695 | Cyclooxygenase 2 inhibitor | 0.113 0.088 DBMET01629 0.113 0.088 DBMET00200 0.194 0.032 DBMET00201 0.695 0.003 DBMET00977 | DBMET00977 | |
| 0.134 | 0.09 | 0.134 | Thiol protease inhibitor | |||
| 0.136 | 0.093 | 0.176 | Anticoagulant | 0.176 0.063 DBMET00201 0.167 0.068 DBMET00977 | DBMET00201 | |
| 0.113 | 0.07 | 0.119 | Caspase 3 inhibitor | 0.119 0.061 DBMET00977 | DBMET00977 | |
| 0.074 | 0.032 | 0.074 | Cannabinoid CB1 receptor agonist | 0.052 0.051 DBMET00201 0.054 0.048 DBMET00977 | ||
| 0.046 | 0.005 | 0.046 | Integrin alpha2beta1 antagonist | 0.043 0.005 DBMET00201 0.046 0.005 DBMET00977 | ||
| 0.046 | 0.004 | 0.046 | Beta 1 adrenoreceptor agonist | 0.021 0.019 DBMET01628 0.024 0.014 DBMET01629 0.021 0.019 DBMET00199 0.024 0.014 DBMET00200 0.027 0.01 DBMET00201 0.024 0.014 DBMET00977 | ||
| 0.094 | 0.053 | 0.098 | Aminoacyl-tRNA synthetase inhibitor | 0.098 0.048 DBMET00201 | DBMET00201 | |
| 0.053 | 0.012 | 0.088 | Phenylethanolamine N methyltransferase inhibitor | 0.043 0.024 DBMET01628 0.046 0.019 DBMET01629 0.043 0.024 DBMET00199 0.046 0.019 DBMET00200 0.062 0.007 DBMET00201 0.088 0.004 DBMET00977 | DBMET00977 | |
| 0.146 | 0.105 | 0.522 | Cyclin-dependent kinase 3 inhibitor | 0.155 0.086 DBMET00201 0.522 0.002 DBMET00977 | DBMET00977 | |
| 0.147 | 0.107 | 0.168 | ATPase inhibitor | 0.168 0.074 DBMET00201 0.165 0.077 DBMET00977 | DBMET00201 | |
| 0.052 | 0.014 | 0.052 | Beta adrenoreceptor agonist | 0.047 0.026 DBMET01628 0.048 0.023 DBMET01629 0.047 0.026 DBMET00199 0.048 0.023 DBMET00200 0.043 0.042 DBMET00977 | ||
| 0.044 | 0.006 | 0.047 | Calcium-sensing receptor agonist | 0.027 0.018 DBMET00201 0.047 0.005 DBMET00977 | DBMET00977 | |
| 0.065 | 0.028 | 0.082 | Neuropeptide Y5 antagonist | 0.082 0.021 DBMET00201 | DBMET00201 | |
| 0.055 | 0.019 | 0.327 | Purinergic P2X4 antagonist | 0.049 0.027 DBMET01628 0.048 0.028 DBMET01629 0.049 0.027 DBMET00199 0.048 0.028 DBMET00200 0.061 0.014 DBMET00201 0.327 0.002 DBMET00977 | DBMET00977 | |
| 0.041 | 0.004 | 0.041 | Angiotensin AT1A receptor antagonist | 0.024 0.011 DBMET01628 0.024 0.01 DBMET01629 0.024 0.011 DBMET00199 0.024 0.01 DBMET00200 0.026 0.009 DBMET00201 | ||
| 0.079 | 0.043 | 0.084 | Aminopeptidase I inhibitor | 0.084 0.038 DBMET00201 0.071 0.052 DBMET00977 | DBMET00201 | |
| 0.055 | 0.023 | 0.055 | Bombesin antagonist | |||
| 0.222 | 0.19 | 0.325 | 15-Lipoxygenase inhibitor | 0.226 0.186 DBMET01628 0.231 0.181 DBMET01629 0.226 0.186 DBMET00199 0.231 0.181 DBMET00200 0.298 0.133 DBMET00201 0.325 0.114 DBMET00977 | DBMET00977 | |
| 0.098 | 0.07 | 0.268 | Urease inhibitor | 0.107 0.059 DBMET01628 0.129 0.037 DBMET01629 0.107 0.059 DBMET00199 0.129 0.037 DBMET00200 0.153 0.021 DBMET00201 0.268 0.006 DBMET00977 | DBMET00977 | |
| 0.037 | 0.01 | 0.037 | Epoxide hydrolase 2 inhibitor | |||
| 0.087 | 0.06 | 0.148 | Bromodomain-containing protein 2 inhibitor | 0.081 0.076 DBMET01628 0.081 0.076 DBMET00199 0.114 0.027 DBMET00201 0.148 0.009 DBMET00977 | DBMET00977 | |
| 0.03 | 0.004 | 0.03 | Angiotensin AT1B receptor antagonist | |||
| 0.036 | 0.01 | 0.067 | CC chemokine 1 receptor antagonist | 0.067 0.005 DBMET00201 0.035 0.01 DBMET00977 | DBMET00201 | |
| 0.034 | 0.009 | 0.039 | Prostaglandin H2 antagonist | 0.029 0.014 DBMET01628 0.034 0.01 DBMET01629 0.029 0.014 DBMET00199 0.034 0.01 DBMET00200 0.039 0.006 DBMET00201 0.036 0.008 DBMET00977 | DBMET00201 | |
| 0.058 | 0.035 | 0.061 | Matrix metalloproteinase (membrane-type) inhibitor | 0.049 0.048 DBMET00201 0.061 0.032 DBMET00977 | DBMET00977 | |
| 0.104 | 0.082 | 0.104 | Proteasome inhibitor | |||
| 0.056 | 0.033 | 0.056 | Acetyl-CoA transferase inhibitor | |||
| 0.057 | 0.034 | 0.061 | Epithelial sodium channel blocker | 0.052 0.045 DBMET00201 0.061 0.027 DBMET00977 | DBMET00977 | |
| 0.025 | 0.004 | 0.027 | CC chemokine 10 receptor antagonist | 0.015 0.011 DBMET01628 0.016 0.009 DBMET01629 0.015 0.011 DBMET00199 0.016 0.009 DBMET00200 0.027 0.003 DBMET00201 0.024 0.004 DBMET00977 | DBMET00201 | |
| 0.097 | 0.076 | 0.106 | Factor V inhibitor | 0.106 0.056 DBMET01628 0.104 0.06 DBMET01629 0.106 0.056 DBMET00199 0.104 0.06 DBMET00200 | DBMET00199 | |
| 0.041 | 0.02 | 0.054 | Glycine transporter 1 inhibitor | 0.054 0.014 DBMET00201 | DBMET00201 | |
| 0.05 | 0.029 | 0.05 | Cytokine production stimulant | |||
| 0.101 | 0.082 | 0.141 | Nav1.5 sodium channel blocker | 0.125 0.048 DBMET00201 0.141 0.033 DBMET00977 | DBMET00977 | |
| 0.028 | 0.009 | 0.031 | Protease (Human cytomegalovirus) inhibitor | 0.031 0.007 DBMET00201 | DBMET00201 | |
| 0.09 | 0.072 | 0.122 | Lanosterol 14 alpha demethylase inhibitor | 0.098 0.058 DBMET00201 0.122 0.029 DBMET00977 | DBMET00977 | |
| 0.081 | 0.063 | 0.081 | Histamine H2 receptor antagonist | |||
| 0.046 | 0.028 | 0.064 | Macrophage elastase inhibitor | 0.064 0.016 DBMET00201 | DBMET00201 | |
| 0.021 | 0.003 | 0.021 | Angiotensin AT2 receptor agonist | 0.011 0.006 DBMET00201 | ||
| 0.039 | 0.023 | 0.04 | Bradykinin antagonist | 0.04 0.021 DBMET00201 | DBMET00201 | |
| 0.067 | 0.052 | 0.213 | Prostaglandin-E synthase inhibitor | 0.08 0.039 DBMET01628 0.08 0.039 DBMET00199 0.071 0.048 DBMET00201 0.213 0.005 DBMET00977 | DBMET00977 | |
| 0.04 | 0.026 | 0.145 | Dihydropteroate synthase inhibitor | 0.04 0.027 DBMET01628 0.036 0.032 DBMET01629 0.04 0.027 DBMET00199 0.036 0.032 DBMET00200 0.058 0.012 DBMET00201 0.145 0.004 DBMET00977 | DBMET00977 | |
| 0.03 | 0.017 | 0.034 | Bradykinin B1 receptor antagonist | 0.034 0.014 DBMET00201 | DBMET00201 | |
| 0.2 | 0.188 | 0.41 | Sodium/bile acid cotransporter inhibitor | 0.41 0.014 DBMET01628 0.258 0.12 DBMET01629 0.41 0.014 DBMET00199 0.258 0.12 DBMET00200 0.326 0.057 DBMET00977 | DBMET00199 | |
| 0.068 | 0.056 | 0.069 | Cathepsin G inhibitor | 0.069 0.054 DBMET00201 0.064 0.061 DBMET00977 | DBMET00201 | |
| 0.016 | 0.005 | 0.016 | Beta 3 adrenoreceptor agonist | |||
| 0.04 | 0.03 | 0.04 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.14 | 0.13 | 0.14 | Neurotensin receptor agonist | |||
| 0.048 | 0.039 | 0.079 | Alpha 1b adrenoreceptor agonist | 0.053 0.03 DBMET01628 0.053 0.029 DBMET01629 0.053 0.03 DBMET00199 0.053 0.029 DBMET00200 0.056 0.025 DBMET00201 0.079 0.008 DBMET00977 | DBMET00977 | |
| 0.068 | 0.059 | 0.149 | Glutamate dehydrogenase inhibitor | 0.149 0.016 DBMET00201 0.083 0.042 DBMET00977 | DBMET00201 | |
| 0.064 | 0.056 | 0.162 | ZAP-70 protein tyrosine kinase inhibitor | 0.082 0.032 DBMET00201 0.162 0.005 DBMET00977 | DBMET00977 | |
| 0.038 | 0.03 | 0.038 | Dopamine D3 agonist | |||
| 0.043 | 0.037 | 0.043 | Potassium channel Kv1.3 blocker | |||
| 0.079 | 0.073 | 0.111 | D-Ala-D-Ala ligase inhibitor | 0.111 0.019 DBMET00201 0.1 0.029 DBMET00977 | DBMET00201 | |
| 0.046 | 0.04 | 0.046 | HCV NS3/NS4A protease inhibitor | |||
| 0.022 | 0.017 | 0.031 | Isoleucine-tRNA ligase inhibitor | 0.024 0.013 DBMET01628 0.024 0.012 DBMET01629 0.024 0.013 DBMET00199 0.024 0.012 DBMET00200 0.031 0.005 DBMET00201 0.025 0.011 DBMET00977 | DBMET00201 | |
| 0.026 | 0.022 | 0.034 | Myristoyl transferase inhibitor | 0.034 0.009 DBMET00977 | DBMET00977 | |
| 0.056 | 0.053 | 0.104 | NMDA receptor agonist | 0.09 0.023 DBMET00201 0.104 0.018 DBMET00977 | DBMET00977 | |
| 0.019 | 0.018 | 0.029 | Factor XIII inhibitor | 0.029 0.005 DBMET00201 0.023 0.01 DBMET00977 | DBMET00201 | |
| 0.017 | 0.016 | 0.019 | Potassium channel (Inward rectifier) 11 blocker | 0.019 0.01 DBMET01628 0.019 0.01 DBMET00199 | DBMET00199 | |
| 0.111 | 0.11 | 0.722 | Cyclooxygenase inhibitor | 0.204 0.041 DBMET00201 0.722 0.003 DBMET00977 | DBMET00977 | |
| 0.105 | 0.104 | 0.321 | Sodium channel (voltage-gated) blocker | 0.205 0.028 DBMET00201 0.321 0.006 DBMET00977 | DBMET00977 | |
| 0.043 | 0.043 | 0.061 | Carnitine palmitoyltransferase 1B inhibitor | 0.061 0.017 DBMET01628 0.061 0.017 DBMET00199 0.06 0.018 DBMET00977 | DBMET00199 | |
| 0.089 | 0.089 | 0.138 | Adenylate kinase inhibitor | 0.138 0.032 DBMET00201 0.109 0.054 DBMET00977 | DBMET00201 | |
| 0.057 | 0.058 | 0.151 | Sphingosine 1-phosphate receptor 4 agonist | 0.151 0.008 DBMET00977 | DBMET00977 | |
| 0.035 | 0.038 | 0.043 | AMPA 4 receptor antagonist | 0.043 0.022 DBMET00977 | DBMET00977 | |
| 0.029 | 0.033 | 0.051 | Carnitine palmitoyltransferase 1 inhibitor | 0.051 0.007 DBMET00977 | DBMET00977 | |
| 0.032 | 0.036 | 0.035 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.035 0.029 DBMET00977 | DBMET00977 | |
| 0.029 | 0.033 | 0.052 | Carnitine palmitoyltransferase inhibitor | 0.052 0.007 DBMET00977 | DBMET00977 | |
| 0.055 | 0.058 | 0.14 | I kappa B kinase 2 inhibitor | 0.14 0.005 DBMET00201 0.14 0.005 DBMET00977 | DBMET00977 | |
| 0.035 | 0.039 | 0.044 | 5 Hydroxytryptamine 2B agonist | 0.044 0.019 DBMET00201 0.044 0.019 DBMET00977 | DBMET00977 | |
| 0.022 | 0.026 | 0.025 | Vanilloid 2 agonist | 0.025 0.019 DBMET00977 | DBMET00977 | |
| 0.025 | 0.029 | 0.043 | Trypsin II inhibitor | 0.043 0.012 DBMET00201 | DBMET00201 | |
| 0.014 | 0.019 | 0.024 | Sodium/hydrogen exchanger inhibitor | 0.024 0.006 DBMET00201 0.019 0.009 DBMET00977 | DBMET00201 | |
| 0.094 | 0.1 | 0.198 | CDK3/cyclin E inhibitor | 0.098 0.091 DBMET01629 0.098 0.091 DBMET00200 0.099 0.089 DBMET00201 0.198 0.007 DBMET00977 | DBMET00977 | |
| 0.025 | 0.031 | 0.043 | 5 Hydroxytryptamine 6 agonist | 0.035 0.01 DBMET00201 0.043 0.006 DBMET00977 | DBMET00977 | |
| 0.119 | 0.127 | 0.201 | Mcl-1 antagonist | 0.171 0.073 DBMET01628 0.14 0.1 DBMET01629 0.171 0.073 DBMET00199 0.14 0.1 DBMET00200 0.17 0.074 DBMET00201 0.201 0.055 DBMET00977 | DBMET00977 | |
| 0.014 | 0.023 | 0.036 | CC chemokine 9 receptor antagonist | 0.023 0.005 DBMET00201 0.036 0.003 DBMET00977 | DBMET00977 | |
| 0.04 | 0.049 | 0.067 | Aldosterone antagonist | 0.067 0.015 DBMET00201 0.058 0.021 DBMET00977 | DBMET00201 | |
| 0.022 | 0.031 | 0.033 | Complement factor 1r inhibitor | 0.031 0.01 DBMET00201 0.033 0.008 DBMET00977 | DBMET00977 | |
| 0.022 | 0.032 | 0.036 | Complement factor 1s inhibitor | 0.036 0.004 DBMET00201 0.029 0.01 DBMET00977 | DBMET00201 | |
| 0.009 | 0.02 | 0.065 | Carbonic anhydrase XI inhibitor | 0.015 0.006 DBMET00201 0.065 0.001 DBMET00977 | DBMET00977 | |
| 0.009 | 0.023 | 0.013 | Human herpes virus 5 capsid protein P40 inhibitor | 0.013 0.009 DBMET00201 | DBMET00201 | |
| 0.011 | 0.025 | 0.064 | Carbonic anhydrase X inhibitor | 0.016 0.012 DBMET00201 0.064 0.002 DBMET00977 | DBMET00977 | |
| 0.011 | 0.025 | 0.064 | Carbonic anhydrase VIII inhibitor | 0.016 0.012 DBMET00201 0.064 0.002 DBMET00977 | DBMET00977 | |
| 0.002 | 0.016 | 0.009 | Glucokinase regulatory protein inhibitor | 0.009 0.002 DBMET00977 | DBMET00977 | |
| 0.128 | 0.143 | 0.153 | MAP kinase kinase 2 inhibitor | 0.153 0.119 DBMET00977 | DBMET00977 | |
| 0.027 | 0.042 | 0.035 | RNA-directed RNA polymerase inhibitor | 0.035 0.023 DBMET00201 | DBMET00201 | |
| 0.029 | 0.045 | 0.065 | Secretase gamma inhibitor | 0.036 0.034 DBMET00201 0.065 0.015 DBMET00977 | DBMET00977 | |
| 0.174 | 0.19 | 0.239 | Tyrosine 3 hydroxylase inhibitor | 0.194 0.147 DBMET00201 0.239 0.079 DBMET00977 | DBMET00977 | |
| 0.141 | 0.159 | 0.276 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.276 0.048 DBMET00201 0.153 0.141 DBMET00977 | DBMET00201 | |
| 0.023 | 0.041 | 0.029 | Cyclophilin A inhibitor | 0.029 0.024 DBMET00201 | DBMET00201 | |
| 0.065 | 0.085 | 0.073 | Glycine receptor antagonist | 0.073 0.068 DBMET00977 | DBMET00977 | |
| 0.023 | 0.043 | 0.05 | ATP citrate lysase inhibitor | 0.05 0.008 DBMET01628 0.042 0.011 DBMET01629 0.05 0.008 DBMET00199 0.042 0.011 DBMET00200 0.03 0.024 DBMET00201 0.041 0.012 DBMET00977 | DBMET00199 | |
| 0.026 | 0.048 | 0.032 | p53 inhibitor | 0.032 0.031 DBMET00977 | DBMET00977 | |
| 0.018 | 0.039 | 0.031 | Growth hormone secretagogue receptor agonist | 0.031 0.026 DBMET00201 | DBMET00201 | |
| 0.029 | 0.051 | 0.213 | Factor Xa inhibitor | 0.082 0.018 DBMET00201 0.213 0.005 DBMET00977 | DBMET00977 | |
| 0.065 | 0.088 | 0.179 | I kappa B kinase inhibitor | 0.164 0.013 DBMET00201 0.179 0.01 DBMET00977 | DBMET00977 | |
| 0.096 | 0.12 | 0.138 | NADPH oxidase inhibitor | 0.12 0.083 DBMET00201 0.138 0.063 DBMET00977 | DBMET00977 | |
| 0.041 | 0.067 | 0.079 | 5 Hydroxytryptamine 6 antagonist | 0.071 0.029 DBMET00201 0.079 0.024 DBMET00977 | DBMET00977 | |
| 0.119 | 0.147 | 0.231 | Antipruritic | 0.14 0.107 DBMET00201 0.231 0.031 DBMET00977 | DBMET00977 | |
| 0.161 | 0.189 | 0.264 | Lipoxygenase inhibitor | 0.264 0.091 DBMET00201 0.264 0.091 DBMET00977 | DBMET00977 | |
| 0.011 | 0.04 | 0.026 | CDK2/cyclin A3 inhibitor | 0.026 0.003 DBMET00977 | DBMET00977 | |
| 0.035 | 0.065 | 0.047 | Alpha 1L adrenoreceptor agonist | 0.047 0.021 DBMET00977 | DBMET00977 | |
| 0.056 | 0.088 | 0.099 | Exportin-1 inhibitor | 0.084 0.02 DBMET00201 0.099 0.009 DBMET00977 | DBMET00977 | |
| 0.021 | 0.053 | 0.043 | Liver X receptor beta agonist | 0.038 0.017 DBMET01629 0.038 0.017 DBMET00200 0.043 0.014 DBMET00977 | DBMET00977 | |
| 0.012 | 0.046 | 0.017 | CXC chemokine 5 receptor antagonist | 0.017 0.014 DBMET00977 | DBMET00977 | |
| 0.175 | 0.21 | 0.25 | MAP kinase kinase 3 inhibitor | 0.25 0.032 DBMET00201 | DBMET00201 | |
| 0.04 | 0.074 | 0.057 | CC chemokine 2 receptor antagonist | 0.057 0.035 DBMET00977 | DBMET00977 | |
| 0.017 | 0.053 | 0.03 | HCV NS5B polymerase inhibitor | 0.03 0.024 DBMET00201 | DBMET00201 | |
| 0.042 | 0.079 | 0.066 | MAP kinase kinase 9 inhibitor | 0.066 0.024 DBMET00977 | DBMET00977 | |
| 0.125 | 0.163 | 0.194 | Potassium channel blocker | 0.194 0.097 DBMET00201 | DBMET00201 | |
| 0.012 | 0.051 | 0.016 | Complement factor 1 inhibitor | 0.016 0.015 DBMET00201 | DBMET00201 | |
| 0.015 | 0.054 | 0.039 | Liver X receptor beta antagonist | 0.039 0.013 DBMET01629 0.039 0.013 DBMET00200 0.039 0.013 DBMET00977 | DBMET00977 | |
| 0.057 | 0.1 | 0.081 | MDM2 inhibitor | 0.068 0.044 DBMET00201 0.081 0.019 DBMET00977 | DBMET00977 | |
| 0.015 | 0.06 | 0.279 | Factor X inhibitor | 0.068 0.016 DBMET00201 0.279 0.005 DBMET00977 | DBMET00977 | |
| 0.009 | 0.054 | 0.115 | Estrone sulfatase inhibitor | 0.115 0.004 DBMET00977 | DBMET00977 | |
| 0.011 | 0.058 | 0.048 | Kynurenine 3 monooxygenase inhibitor | 0.031 0.014 DBMET00201 0.048 0.007 DBMET00977 | DBMET00977 | |
| 0.027 | 0.073 | 0.041 | Thymidylate synthase inhibitor | 0.041 0.04 DBMET00201 | DBMET00201 | |
| 0.07 | 0.118 | 0.121 | CC chemokine 5 receptor agonist | 0.121 0.008 DBMET00977 | DBMET00977 | |
| 0.084 | 0.132 | 0.106 | Cyclooxygenase 3 inhibitor | 0.106 0.095 DBMET00977 | DBMET00977 | |
| 0.049 | 0.102 | 0.248 | I kappa B kinase 1 inhibitor | 0.132 0.012 DBMET00201 0.248 0.005 DBMET00977 | DBMET00977 | |
| 0.015 | 0.068 | 0.039 | Kainate receptor 2 antagonist | 0.039 0.023 DBMET00977 | DBMET00977 | |
| 0.018 | 0.072 | 0.037 | Kainate receptor antagonist | 0.037 0.032 DBMET00977 | DBMET00977 | |
| 0.043 | 0.098 | 0.088 | Potassium channel intermediate-conductance Ca-activated blocker | 0.068 0.029 DBMET00201 0.088 0.013 DBMET00977 | DBMET00977 | |
| 0.034 | 0.09 | 0.119 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.048 0.047 DBMET01628 0.072 0.02 DBMET01629 0.048 0.047 DBMET00199 0.072 0.02 DBMET00200 0.074 0.019 DBMET00201 0.119 0.008 DBMET00977 | DBMET00977 | |
| 0.024 | 0.083 | 0.042 | AMPA receptor antagonist | 0.042 0.04 DBMET00977 | DBMET00977 | |
| 0.079 | 0.138 | 0.139 | Calcium channel N-type blocker | 0.139 0.045 DBMET00977 | DBMET00977 | |
| 0.01 | 0.07 | 0.022 | Glutamate (mGluR1a) agonist | 0.022 0.015 DBMET00201 0.021 0.017 DBMET00977 | DBMET00201 | |
| 0.053 | 0.116 | 0.103 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.103 0.012 DBMET00977 | DBMET00977 | |
| 0.102 | 0.168 | 0.136 | LIM domain kinase 1 inhibitor | 0.136 0.114 DBMET00201 | DBMET00201 | |
| 0.033 | 0.098 | 0.093 | CXC chemokine 1 receptor antagonist | 0.046 0.045 DBMET01628 0.046 0.045 DBMET00199 0.051 0.036 DBMET00201 0.093 0.006 DBMET00977 | DBMET00977 | |
| 0.063 | 0.129 | 0.143 | NADH dehydrogenase inhibitor | 0.084 0.067 DBMET01629 0.084 0.067 DBMET00200 0.103 0.041 DBMET00201 0.143 0.019 DBMET00977 | DBMET00977 | |
| 0.139 | 0.206 | 0.222 | Superoxide dismutase inhibitor | 0.222 0.096 DBMET00201 | DBMET00201 | |
| 0.065 | 0.133 | 0.082 | Thioredoxin inhibitor | 0.082 0.078 DBMET00977 | DBMET00977 | |
| 0.039 | 0.107 | 0.062 | Purinergic P2X1 antagonist | 0.056 0.049 DBMET01628 0.056 0.049 DBMET00199 0.062 0.041 DBMET00977 | DBMET00977 | |
| 0.041 | 0.109 | 0.189 | Nav1.7 sodium channel blocker | 0.12 0.017 DBMET00201 0.189 0.007 DBMET00977 | DBMET00977 | |
| 0.012 | 0.081 | 0.029 | Sirtuin 2 inhibitor | 0.029 0.028 DBMET00977 | DBMET00977 | |
| 0.01 | 0.08 | 0.042 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.033 0.015 DBMET00201 0.042 0.01 DBMET00977 | DBMET00977 | |
| 0.119 | 0.19 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.151 0.039 DBMET00977 | DBMET00977 | |
| 0.012 | 0.082 | 0.023 | Prostaglandin F2 alpha agonist | 0.023 0.015 DBMET00977 | DBMET00977 | |
| 0.028 | 0.099 | 0.069 | Kainate receptor agonist | 0.042 0.027 DBMET00201 0.069 0.005 DBMET00977 | DBMET00977 | |
| 0.097 | 0.169 | 0.175 | Aurora-C kinase inhibitor | 0.175 0.029 DBMET00977 | DBMET00977 | |
| 0.028 | 0.1 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.033 DBMET00201 0.051 0.013 DBMET00977 | DBMET00977 | |
| 0.024 | 0.099 | 0.061 | Bromodomain-containing protein 3 inhibitor | 0.051 0.032 DBMET01628 0.051 0.032 DBMET00199 0.061 0.019 DBMET00977 | DBMET00977 | |
| 0.069 | 0.145 | 0.173 | Amylase inhibitor | 0.149 0.065 DBMET00201 0.173 0.054 DBMET00977 | DBMET00977 | |
| 0.034 | 0.11 | 0.131 | Cyclin H inhibitor | 0.131 0.004 DBMET00977 | DBMET00977 | |
| 0.087 | 0.166 | 0.121 | Sphingosine 1-phosphate receptor 4 antagonist | 0.121 0.07 DBMET00977 | DBMET00977 | |
| 0.016 | 0.097 | 0.062 | Urokinase inhibitor | 0.062 0.027 DBMET00201 | DBMET00201 | |
| 0.011 | 0.094 | 0.03 | Carnitine palmitoyltransferase 1A inhibitor | 0.03 0.018 DBMET00977 | DBMET00977 | |
| 0.047 | 0.131 | 0.075 | Transcription factor RelA inhibitor | 0.067 0.036 DBMET00201 0.075 0.023 DBMET00977 | DBMET00977 | |
| 0.102 | 0.189 | 0.168 | Sphingosine 1-phosphate receptor 5 antagonist | 0.168 0.036 DBMET00977 | DBMET00977 | |
| 0.027 | 0.12 | 0.045 | Glutamate (mGluR4) antagonist | 0.045 0.028 DBMET00977 | DBMET00977 | |
| 0.057 | 0.15 | 0.112 | Triose-phosphate isomerase inhibitor | 0.09 0.059 DBMET00201 0.112 0.037 DBMET00977 | DBMET00977 | |
| 0.065 | 0.158 | 0.115 | GABA C receptor antagonist | 0.115 0.058 DBMET00977 | DBMET00977 | |
| 0.013 | 0.107 | 0.039 | TRPM8 blocker | 0.039 0.025 DBMET00977 | DBMET00977 | |
| 0.066 | 0.162 | 0.674 | Cyclooxygenase 1 inhibitor | 0.124 0.077 DBMET00201 0.674 0.004 DBMET00977 | DBMET00977 | |
| 0.012 | 0.108 | 0.035 | LFA antagonist | 0.035 0.011 DBMET00977 | DBMET00977 | |
| 0.066 | 0.163 | 0.097 | Glutamate release inhibitor | 0.097 0.048 DBMET00977 | DBMET00977 | |
| 0.021 | 0.118 | 0.043 | Liver X receptor agonist | 0.043 0.03 DBMET01629 0.043 0.03 DBMET00200 0.043 0.031 DBMET00977 | DBMET00977 | |
| 0.027 | 0.127 | 0.083 | Carbamoyl phosphate synthetase inhibitor | 0.083 0.027 DBMET00201 0.061 0.042 DBMET00977 | DBMET00201 | |
| 0.025 | 0.126 | 0.061 | CDK7/cyclin H inhibitor | 0.061 0.015 DBMET00977 | DBMET00977 | |
| 0.012 | 0.116 | 0.033 | Phosphoglycerate kinase inhibitor | 0.033 0.027 DBMET00977 | DBMET00977 | |
| 0.024 | 0.131 | 0.076 | NMDA receptor glycine site agonist | 0.076 0.031 DBMET00201 0.061 0.045 DBMET00977 | DBMET00201 | |
| 0.022 | 0.132 | 0.069 | AICAR transformylase inhibitor | 0.069 0.01 DBMET00977 | DBMET00977 | |
| 0.041 | 0.157 | 0.075 | Somatostatin 1 agonist | 0.075 0.057 DBMET00201 | DBMET00201 | |
| 0.221 | 0.338 | 0.295 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.271 0.254 DBMET00201 0.295 0.22 DBMET00977 | DBMET00977 | |
| 0.118 | 0.235 | 0.269 | Histone acetyltransferase inhibitor | 0.194 0.079 DBMET00201 0.269 0.02 DBMET00977 | DBMET00977 | |
| 0.005 | 0.125 | 0.015 | Alpha 2a adrenoreceptor agonist | 0.015 0.014 DBMET00977 | DBMET00977 | |
| 0.053 | 0.173 | 0.155 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.112 0.044 DBMET00201 0.155 0.025 DBMET00977 | DBMET00977 | |
| 0.051 | 0.172 | 0.077 | GABA B receptor agonist | 0.077 0.049 DBMET00977 | DBMET00977 | |
| 0.14 | 0.263 | 0.38 | Transcription factor STAT inhibitor | 0.195 0.145 DBMET00201 0.38 0.024 DBMET00977 | DBMET00977 | |
| 0.008 | 0.132 | 0.028 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.026 DBMET00977 | DBMET00977 | |
| 0.035 | 0.161 | 0.059 | Pregnane X receptor antagonist | 0.059 0.032 DBMET00977 | DBMET00977 | |
| 0.018 | 0.145 | 0.054 | Liver X receptor alpha agonist | 0.054 0.016 DBMET00977 | DBMET00977 | |
| 0.021 | 0.149 | 0.065 | Alcohol oxidase inhibitor | 0.065 0.032 DBMET00201 | DBMET00201 | |
| 0.025 | 0.154 | 0.047 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.035 DBMET00977 | DBMET00977 | |
| 0.102 | 0.233 | 0.202 | MAP kinase kinase 4 inhibitor | 0.202 0.013 DBMET00977 | DBMET00977 | |
| 0.18 | 0.312 | 0.348 | MAP kinase kinase 6 inhibitor | 0.348 0.094 DBMET00201 | DBMET00201 | |
| 0.019 | 0.154 | 0.062 | Mineralocorticoid receptor antagonist | 0.062 0.019 DBMET00201 | DBMET00201 | |
| 0.082 | 0.219 | 0.333 | Amyloid beta precursor protein antagonist | 0.333 0.011 DBMET00977 | DBMET00977 | |
| 0.088 | 0.225 | 0.157 | Insulin sensitizer | 0.157 0.124 DBMET00201 | DBMET00201 | |
| 0.012 | 0.152 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.018 DBMET00977 | DBMET00977 | |
| 0.089 | 0.233 | 0.465 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.465 0.025 DBMET00977 | DBMET00977 | |
| 0.044 | 0.192 | 0.118 | Creatine kinase inhibitor | 0.118 0.042 DBMET00977 | DBMET00977 | |
| 0.041 | 0.189 | 0.249 | CDK2/cyclin A inhibitor | 0.249 0.009 DBMET00977 | DBMET00977 | |
| 0.021 | 0.17 | 0.061 | Phosphofructokinase-1 inhibitor | 0.061 0.056 DBMET00977 | DBMET00977 | |
| 0.045 | 0.195 | 0.065 | Calcium channel P-type blocker | 0.065 0.039 DBMET00977 | DBMET00977 | |
| 0.009 | 0.162 | 0.035 | Vascular adhesion protein 1 inhibitor | 0.035 0.033 DBMET00977 | DBMET00977 | |
| 0.066 | 0.221 | 0.221 | Peroxidase inhibitor | 0.221 0.054 DBMET01629 0.221 0.054 DBMET00200 0.218 0.054 DBMET00201 0.138 0.085 DBMET00977 | DBMET00200 | |
| 0.046 | 0.202 | 0.125 | GABA C receptor agonist | 0.098 0.069 DBMET00201 0.125 0.046 DBMET00977 | DBMET00977 | |
| 0.025 | 0.182 | 0.096 | Leukotriene synthesis inhibitor | 0.096 0.028 DBMET00201 | DBMET00201 | |
| 0.079 | 0.24 | 0.118 | DNA repair enzyme inhibitor | 0.118 0.076 DBMET00977 | DBMET00977 | |
| 0.122 | 0.284 | 0.197 | RNA-directed DNA polymerase inhibitor | 0.173 0.146 DBMET00201 0.197 0.105 DBMET00977 | DBMET00977 | |
| 0.055 | 0.219 | 0.16 | Alpha-N-acetylglucosaminidase inhibitor | 0.16 0.049 DBMET00977 | DBMET00977 | |
| 0.088 | 0.253 | 0.257 | CF transmembrane conductance regulator agonist | 0.257 0.005 DBMET00977 | DBMET00977 | |
| 0.044 | 0.211 | 0.116 | Ferrochelatase inhibitor | 0.116 0.056 DBMET00977 | DBMET00977 | |
| 0.058 | 0.225 | 0.138 | Phosphodiesterase 6D inhibitor | 0.138 0.014 DBMET00977 | DBMET00977 | |
| 0.078 | 0.255 | 0.139 | GABA C receptor rho-2 antagonist | 0.139 0.09 DBMET00977 | DBMET00977 | |
| 0.038 | 0.22 | 0.068 | Glutamate (mGluR6) antagonist | 0.068 0.043 DBMET00977 | DBMET00977 | |
| 0.047 | 0.231 | 0.288 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.177 0.061 DBMET00201 0.288 0.029 DBMET00977 | DBMET00977 | |
| 0.04 | 0.225 | 0.105 | HIV-1 integrase (Overall Integration) inhibitor | 0.102 0.052 DBMET00201 0.105 0.05 DBMET00977 | DBMET00977 | |
| 0.024 | 0.21 | 0.071 | Glutamate decarboxylase inhibitor | 0.071 0.053 DBMET00201 | DBMET00201 | |
| 0.049 | 0.236 | 0.116 | Interleukin 5 antagonist | 0.116 0.026 DBMET00977 | DBMET00977 | |
| 0.027 | 0.215 | 0.042 | Heme oxygenase inhibitor | 0.042 0.034 DBMET00977 | DBMET00977 | |
| 0.034 | 0.225 | 0.12 | 5-Lipoxygenase inhibitor | 0.12 0.05 DBMET00201 0.117 0.051 DBMET00977 | DBMET00201 | |
| 0.066 | 0.26 | 0.15 | Arachidonic acid antagonist | 0.15 0.089 DBMET00977 | DBMET00977 | |
| 0.027 | 0.223 | 0.098 | Calcium antagonist | 0.098 0.05 DBMET00977 | DBMET00977 | |
| 0.015 | 0.211 | 0.036 | Glutamate (mGluR4) agonist | 0.036 0.019 DBMET00977 | DBMET00977 | |
| 0.02 | 0.216 | 0.05 | Aconitate hydratase inhibitor | 0.05 0.039 DBMET00201 | DBMET00201 | |
| 0.005 | 0.202 | 0.027 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.027 0.013 DBMET00977 | DBMET00977 | |
| 0.061 | 0.259 | 0.364 | Dual specificity phosphatase 3 inhibitor | 0.364 0.018 DBMET00977 | DBMET00977 | |
| 0.028 | 0.226 | 0.057 | Heat shock protein 90 beta antagonist | 0.057 0.044 DBMET00977 | DBMET00977 | |
| 0.021 | 0.23 | 0.077 | Cyclin D1 inhibitor | 0.077 0.021 DBMET00977 | DBMET00977 | |
| 0.065 | 0.276 | 0.219 | Mannose-6-phosphate isomerase inhibitor | 0.153 0.062 DBMET00201 0.219 0.022 DBMET00977 | DBMET00977 | |
| 0.106 | 0.32 | 0.256 | Alpha-glucosidase inhibitor | 0.256 0.184 DBMET00977 | DBMET00977 | |
| 0.037 | 0.256 | 0.106 | UDP-glucose 4-epimerase inhibitor | 0.106 0.055 DBMET00977 | DBMET00977 | |
| 0.008 | 0.228 | 0.03 | MAP3K8 inhibitor | 0.03 0.018 DBMET00977 | DBMET00977 | |
| 0.025 | 0.245 | 0.054 | Dihydroorotate oxidase inhibitor | 0.054 0.04 DBMET00977 | DBMET00977 | |
| 0.13 | 0.351 | 0.249 | Calcium channel activator | 0.249 0.148 DBMET00977 | DBMET00977 | |
| 0.014 | 0.236 | 0.112 | CDK9/cyclin T1 inhibitor | 0.112 0.016 DBMET00977 | DBMET00977 | |
| 0.118 | 0.342 | 0.197 | Nitric-oxide synthase stimulant | 0.197 0.093 DBMET00977 | DBMET00977 | |
| 0.105 | 0.329 | 0.242 | DNA polymerase beta inhibitor | 0.242 0.197 DBMET00977 | DBMET00977 | |
| 0.023 | 0.251 | 0.124 | Cyclin B3 inhibitor | 0.124 0.02 DBMET00977 | DBMET00977 | |
| 0.006 | 0.241 | 0.048 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.047 0.017 DBMET01629 0.047 0.017 DBMET00200 0.048 0.017 DBMET00977 | DBMET00977 | |
| 0.009 | 0.244 | 0.036 | Alpha 1d adrenoreceptor agonist | 0.036 0.031 DBMET00977 | DBMET00977 | |
| 0.033 | 0.27 | 0.18 | Cyclin-dependent kinase 9 inhibitor | 0.18 0.027 DBMET00977 | DBMET00977 | |
| 0.04 | 0.278 | 0.102 | MAP kinase kinase 1 inhibitor | 0.102 0.054 DBMET00977 | DBMET00977 | |
| 0.009 | 0.249 | 0.057 | CDK4/cyclin D3 inhibitor | 0.057 0.005 DBMET00977 | DBMET00977 | |
| 0.006 | 0.247 | 0.028 | Potassium channel small-conductance Ca-activated activator | 0.028 0.026 DBMET00977 | DBMET00977 | |
| 0.021 | 0.263 | 0.531 | Cyclin-dependent kinase 1 inhibitor | 0.531 0.005 DBMET00977 | DBMET00977 | |
| 0.031 | 0.275 | 0.064 | Phosphodiesterase 1C inhibitor | 0.064 0.04 DBMET00977 | DBMET00977 | |
| 0.013 | 0.264 | 0.076 | Cyclin B inhibitor | 0.076 0.017 DBMET00977 | DBMET00977 | |
| 0.026 | 0.281 | 0.086 | Alcohol dehydrogenase inhibitor | 0.086 0.069 DBMET00977 | DBMET00977 | |
| 0.016 | 0.272 | 0.041 | Glutamate (mGluR group III) agonist | 0.041 0.033 DBMET00977 | DBMET00977 | |
| 0.01 | 0.27 | 0.066 | Glutamate (mGluR3) antagonist | 0.066 0.007 DBMET00977 | DBMET00977 | |
| 0.017 | 0.28 | 0.061 | Phenylalanine 4-hydroxylase inhibitor | 0.061 0.057 DBMET00977 | DBMET00977 | |
| 0.032 | 0.295 | 0.093 | Phosphodiesterase VI inhibitor | 0.093 0.025 DBMET00977 | DBMET00977 | |
| 0.05 | 0.318 | 0.283 | Dual specificity phosphatase inhibitor | 0.283 0.031 DBMET00977 | DBMET00977 | |
| 0.008 | 0.278 | 0.054 | Aromatase inhibitor | 0.054 0.046 DBMET00977 | DBMET00977 | |
| 0.004 | 0.275 | 0.014 | Thyroid hormone alpha antagonist | 0.014 0.013 DBMET01628 0.014 0.013 DBMET00199 | DBMET00199 | |
| 0.009 | 0.28 | 0.109 | CDK1/cyclin B inhibitor | 0.109 0.021 DBMET00977 | DBMET00977 | |
| 0.03 | 0.306 | 0.129 | Cystathionine beta-synthase inhibitor | 0.129 0.052 DBMET00977 | DBMET00977 | |
| 0.012 | 0.297 | 0.069 | Cyclin-dependent kinase 6 inhibitor | 0.069 0.032 DBMET00977 | DBMET00977 | |
| 0.013 | 0.299 | 0.096 | Cyclin B1 inhibitor | 0.096 0.013 DBMET00977 | DBMET00977 | |
| 0.012 | 0.303 | 0.072 | Cyclin A inhibitor | 0.072 0.036 DBMET00977 | DBMET00977 | |
| 0.013 | 0.306 | 0.079 | Cyclin A2 inhibitor | 0.079 0.033 DBMET00977 | DBMET00977 | |
| 0.004 | 0.299 | 0.044 | Estradiol 17 beta-dehydrogenase inhibitor | 0.044 0.028 DBMET00977 | DBMET00977 | |
| 0.01 | 0.306 | 0.087 | Cyclin B2 inhibitor | 0.087 0.012 DBMET00977 | DBMET00977 | |
| 0.021 | 0.334 | 0.373 | Cyclin-dependent kinase 2 inhibitor | 0.373 0.009 DBMET00977 | DBMET00977 | |
| 0.041 | 0.355 | 0.11 | DOPA decarboxylase inhibitor | 0.11 0.058 DBMET00977 | DBMET00977 | |
| 0.063 | 0.385 | 0.189 | Thioredoxin glutathione reductase inhibitor | 0.189 0.182 DBMET00977 | DBMET00977 | |
| 0.034 | 0.363 | 0.171 | Protein kinase (CK1) gamma 1 inhibitor | 0.171 0.055 DBMET00977 | DBMET00977 | |
| 0.009 | 0.35 | 0.073 | Phosphodiesterase VII inhibitor | 0.073 0.032 DBMET00977 | DBMET00977 | |
| 0.038 | 0.382 | 0.145 | Cell wall synthesis inhibitor | 0.145 0.07 DBMET00977 | DBMET00977 | |
| 0.095 | 0.439 | 0.15 | Heat shock protein 70 antagonist | 0.15 0.044 DBMET00977 | DBMET00977 | |
| 0.122 | 0.472 | 0.292 | 5 Hydroxytryptamine release inhibitor | 0.292 0.174 DBMET00977 | DBMET00977 | |
| 0.014 | 0.365 | 0.051 | Phosphodiesterase 7A inhibitor | 0.051 0.038 DBMET00977 | DBMET00977 | |
| 0.086 | 0.445 | 0.301 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.301 0.063 DBMET00977 | DBMET00977 | |
| 0.052 | 0.425 | 0.149 | 3C-like protease (Human coronavirus) inhibitor | 0.149 0.102 DBMET00977 | DBMET00977 | |
| 0.017 | 0.391 | 0.135 | CDK/cyclin complex inhibitor | 0.135 0.035 DBMET00977 | DBMET00977 | |
| 0.031 | 0.407 | 0.173 | I kappa B kinase epsilon inhibitor | 0.173 0.097 DBMET00977 | DBMET00977 | |
| 0.09 | 0.465 | 0.239 | Caspase 3 stimulant | 0.239 0.122 DBMET00977 | DBMET00977 | |
| 0.042 | 0.42 | 0.145 | DNA methyltransferase I inhibitor | 0.145 0.109 DBMET00977 | DBMET00977 | |
| 0.025 | 0.421 | 0.118 | Cytidine deaminase inhibitor | 0.118 0.103 DBMET00977 | DBMET00977 | |
| 0.012 | 0.416 | 0.193 | CDK1/cyclin B1 inhibitor | 0.193 0.009 DBMET00977 | DBMET00977 | |
| 0.041 | 0.451 | 0.146 | DNA methylase inhibitor | 0.146 0.121 DBMET00977 | DBMET00977 | |
| 0.031 | 0.441 | 0.102 | Phosphodiesterase 7B inhibitor | 0.102 0.055 DBMET00977 | DBMET00977 | |
| 0.03 | 0.456 | 0.155 | Activin receptor-like kinase 2 inhibitor | 0.155 0.063 DBMET00977 | DBMET00977 | |
| 0.014 | 0.444 | 0.067 | Aryl hydrocarbon receptor antagonist | 0.067 0.042 DBMET00977 | DBMET00977 | |
| 0.049 | 0.487 | 0.139 | MAP kinase 3 inhibitor | 0.139 0.088 DBMET00977 | DBMET00977 | |
| 0.013 | 0.461 | 0.26 | Nav1.8 sodium channel blocker | 0.26 0.005 DBMET00977 | DBMET00977 | |
| 0.024 | 0.471 | 0.154 | ErbB-3 antagonist | 0.154 0.018 DBMET00977 | DBMET00977 | |
| 0.024 | 0.478 | 0.14 | DNA directed RNA polymerase inhibitor | 0.14 0.028 DBMET00977 | DBMET00977 | |
| 0.017 | 0.475 | 0.174 | Cyclin-dependent kinase inhibitor | 0.174 0.046 DBMET00977 | DBMET00977 | |
| 0.032 | 0.494 | 0.16 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.16 0.115 DBMET00977 | DBMET00977 | |
| 0.019 | 0.483 | 0.19 | Aryl hydrocarbon receptor agonist | 0.19 0.108 DBMET00977 | DBMET00977 | |
| 0.087 | 0.564 | 0.75 | Antiinflammatory | 0.75 0.023 DBMET01628 0.729 0.026 DBMET01629 0.75 0.023 DBMET00199 0.729 0.026 DBMET00200 | DBMET00199 | |
| 0.025 | 0.503 | 0.278 | EphB2 antagonist | 0.278 0.043 DBMET00977 | DBMET00977 | |
| 0.018 | 0.52 | 0.157 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.157 0.084 DBMET00977 | DBMET00977 | |
| 0.031 | 0.618 | 0.103 | Transcription factor STAT6 inhibitor | 0.103 0.099 DBMET00977 | DBMET00977 | |
| 0.028 | 0.755 | 0.42 | Apoptosis agonist | 0.359 0.134 DBMET01628 0.42 0.104 DBMET01629 0.359 0.134 DBMET00199 0.42 0.104 DBMET00200 | DBMET00200 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |